300363.SZ
博腾股份
SZSE · Healthcare · C 制造业 · CN
CNY 20.46
−6.53%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 3.5B | 3.4B | 3.0B | 3.7B | 7.0B |
| Cost of Revenue | 2.4B | 2.4B | 2.3B | 2.2B | 3.4B |
| Gross Profit | 1.1B | 1.0B | 740.6M | 1.5B | 3.7B |
| Operating Expenses | |||||
| R&D Expense | 239.8M | 267.6M | 338.5M | 452.2M | 519.5M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 393.8M | 384.3M | 397.9M | 548.5M | 604.4M |
| Selling & Marketing Expense | 203.0M | 175.1M | 159.9M | 144.7M | 203.3M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 952.9M | 926.4M | 949.0M | 1.2B | 1.4B |
| Cost and Expenses | 3.4B | 3.3B | 3.2B | 3.4B | 4.7B |
| Operating Income (EBIT) | 120.1M | 92.9M | (342.5M) | 268.9M | 2.3B |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 107.4M | 82.7M | (374.0M) | 246.6M | 2.2B |
| Income Tax Expense | 45.2M | 52.3M | (8.1M) | 71.0M | 309.4M |
| Bottom Line | |||||
| Net Income | 128.5M | 96.3M | (287.8M) | 266.9M | 2.0B |
| Earnings from Cont. Ops | 62.2M | 30.4M | (366.0M) | 175.5M | 1.9B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 128.5M | 96.3M | (287.8M) | 266.9M | 2.0B |
| Per Share | |||||
| Basic EPS | CN¥0.24 | CN¥0.18 | (CN¥0.53) | CN¥0.49 | CN¥3.70 |
| Diluted EPS | CN¥0.24 | CN¥0.18 | (CN¥0.53) | CN¥0.49 | CN¥3.69 |
| Revenue Per Share | CN¥6.29 | CN¥6.39 | CN¥5.55 | CN¥6.73 | CN¥12.98 |
| Shares | |||||
| Basic Shares Outstanding | 557.3M | 535.2M | 542.9M | 544.6M | 542.0M |
| Diluted Shares Outstanding | 557.3M | 535.2M | 542.9M | 544.6M | 542.0M |
| Profitability Metrics | |||||
| EBITDA | — | 498.5M | 27.6M | 588.0M | 2.5B |
| D&A | — | 405.6M | 370.1M | 319.1M | 241.4M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026